Evidence map›Paper›PMID 41439682›Full record

ArticleAnalytical chemistry2026

Reducing Bias in Mass Cytometry Data through Corrections for Spillover and Nonspecific Binding.

Kris Elbein, Nameera Wegner, Edgar A Arriaga

Abstract read
In one paragraph

Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kris ElbeinDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States.ORCID 0000-0001-9816-1707
Nameera WegnerDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Edgar A ArriagaDepartment of Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States.ORCID 0000-0001-8863-6174

Funding

Training Grant: Functional Proteomics of AgingT32AG029796 · NIA · UNIVERSITY OF MINNESOTA · PI EDGAR A ARRIAGA, Douglas G Mashek · 2008 to 2026
$6.6M
Quantitating Mitophagy in Skeletal Muscle ModelsR01AG020866 · NIA · UNIVERSITY OF MINNESOTA TWIN CITIES · PI ARRIAGA, EDGAR A · 2002 to 2021
$5.7M
Single-Cell Molecular Pathway Analysis in Aging Systems via Novel Mass Cytometry MethodsR01AG084804 · NIA · UNIVERSITY OF MINNESOTA · PI EDGAR A ARRIAGA, MARK D DISTEFANO · 2024 to 2026
$1.4M
NIA NIH HHS R01 AG020866NIA NIH HHS R01 AG084804NIA NIH HHS T32 AG029796
6 · The paper itself

Abstract

Mass cytometry can facilitate the study of over 40 protein markers in single cells, making it an ideal technique to investigate complex biological systems. The use of antibodies tagged with metal isotopes as probes makes mass cytometry measurements susceptible to isotopic spillover. In this report, we introduce ccSpill, an instrument-specific matrix built from calibration curves of metal-labeled antibodies and solutions of pure metals that can be applied to single-cell data to remove spillover. ccSpill is unique to each lab, and each set of reporter antibodies and is compatible with isotype-based nonspecific binding (NSB) corrections. We demonstrate that combining ccSpill with NSB corrections is integral to the optimization of sample preparation procedures that involve challenging antibodies and that such a correction identifies and excludes cell artifacts in single-cell analyses. Furthermore, the combined correction demonstrated that low metal ion/antibody ratios are detrimental to capturing features at the edges of single-cell distributions, which are misassigned without a correction. Lastly, by applying the combined correction to phenotypic markers, the identification of cell types was highly enhanced. Combined corrections of spillover and NSB provide a gateway to use mass cytometry unequivocally to characterize rare cells (e.g., senescent), subtypes (e.g., endothelial), or treatment (e.g., rapamycin), which is highly needed in clinical and biomedical research.

Indexed as

Flow CytometryMass SpectrometrySingle-Cell AnalysisAntibodiesHumansMetalsAntibodiesMetals

Identifiers

PMID41439682
PMCPMC12758627

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.